The Waitlist Squeeze and the Evidence Base
You direct a small community mental health clinic with four licensed clinicians and two interns. The county has cut funding, and your waitlist has grown to 90 people with an average wait of 11 weeks. Most referrals are for depression and anxiety; a large share are Spanish-speaking, and only one clinician is conversationally fluent (not a certified interpreter). The board pressures you to 'do more with less' and suggests shortening sessions to 30 minutes, doubling caseloads, and dropping group therapy because 'individual therapy is what people want.' You have outcome data showing your clinic's individual therapy produces moderate effects (d ≈ 0.5), and a pilot of a structured transdiagnostic group produced larger effects (d ≈ 0.8) at one-third the clinician-hours per client. Staff are exhausted and two have mentioned leaving.
1. Using evidence-based practice principles, evaluate the board's three suggestions and propose an alternative service design.
Read the worked answer
Evidence-based practice is the integration of best available research, clinical expertise, and patient values/preferences (APA Presidential Task Force, 2006) - not 'whatever the board prefers' and not 'whatever the data say' in isolation. Evaluate each suggestion:
- 30-minute sessions: Session length is not itself the active ingredient; dose and content matter. Shortening without an evidence-based rationale risks degrading outcomes and is not supported by your own data. Reject as a blanket policy; consider targeted brief protocols (e.g., behavioral activation) for specific presentations where evidence supports them.
- Doubling caseloads: Pushing clinicians past sustainable loads predicts burnout, turnover, and worse outcomes - and turnover destroys the continuity that makes therapy work. This trades long-term capacity for short-term optics. Reject.
- Dropping group therapy: This is the opposite of what your data support. Your own pilot shows the group is more effective (d ≈ 0.8 vs 0.5) and far more efficient per clinician-hour. Dropping it would sacrifice both outcomes and access. Reject - and expand it.
Alternative design: (a) Scale the transdiagnostic group as the front-door intervention for depression/anxiety, with individual therapy reserved for complexity, risk, and preference. (b) Implement a stepped-care model: psychoeducation and guided self-help for mild presentations, group for moderate, individual for severe. (c) Use measurement-based care (routine outcome monitoring) to triage and to catch non-responders early. (d) Address the language gap with certified interpreter services and, longer term, hiring/bilingual pay incentives - 'conversational' fluency is not adequate for clinical care. (e) Manage the waitlist actively: brief intake/consult, safety planning, and referral pathways for those who can be served elsewhere. (f) Protect staff via realistic productivity targets and supervision. This design is defensible to the board because it is grounded in your own outcome data and in the stepped-care literature, and it serves more people better rather than more people worse.
2. How would you handle the language-access problem ethically and practically, given that only one clinician is conversationally fluent?
Read the worked answer
Language access is an ethical obligation (justice and respect for persons; APA Standards 2.01 and 3.01 on competence and avoiding discrimination) and often a legal one (e.g., Title VI obligations for federally funded programs, which your county-funded clinic likely is). 'Conversational' fluency is not the same as clinical proficiency - conducting assessment and therapy in a second language requires the ability to handle nuance, idioms of distress, and risk assessment. Relying on one clinician for all Spanish-speaking clients creates a bottleneck and an equity problem.
Practical steps: (1) Contract certified medical interpreters (not family members, not untrained bilingual staff) for assessment and therapy; train clinicians in working with interpreters (briefing, positioning, speaking in first person, checking understanding). (2) Do not use the fluent clinician as an unpaid translation service for colleagues' sessions - that is a dual role and a boundary problem. (3) Use validated translated measures where they exist rather than ad hoc translation. (4) Build capacity: offer language proficiency assessment and pay differentials, recruit bilingual clinicians, and partner with local training programs. (5) Be transparent with clients about interpreter use and document it. (6) Track access metrics by language to ensure Spanish-speaking clients are not waiting longer than others - an equity audit. The goal is not 'one bilingual clinician' but a system where language is not a barrier to timely, competent care.